KYTX · Kyverna Therapeutics, Inc.
Market Cap
$517.63M
Shares
61.84M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-13 | 51 | $8.05 | $411 |
| 2026-08-12 | 48,700 | $8.02 | $390,574 |
| 2026-08-05 | 20,693 | $7.78 | $160,992 |
| 2026-08-04 | 701 | $7.51 | $5,265 |
| 2026-08-03 | 2,845 | $7.30 | $20,769 |
| 2026-07-24 | 55 | $7.29 | $401 |
| 2026-07-01 | 151,867 | $8.91 | $1,353,135 |
| 2026-06-29 | 35,469 | $8.44 | $299,358 |
| 2026-06-26 | 26,700 | $8.20 | $218,940 |
| 2026-06-22 | 2,699 | $8.07 | $21,781 |
| 2026-06-15 | 1,408 | $8.06 | $11,348 |
| 2026-06-12 | 2,382 | $7.87 | $18,746 |
| 2026-06-10 | 59 | $7.85 | $463 |
| 2026-06-09 | 293 | $7.71 | $2,259 |
| 2026-06-08 | 2,704 | $7.47 | $20,199 |
| 2026-06-05 | 14 | $7.95 | $111 |
Showing 1–16 of 16 settlements
Key facts
CIK
1994702
CUSIP
501976104
13F (30d)
100 filings
100 filers
Visit website
Investor relations